Real-world effectiveness of smoking cessation strategies for young and older adults: Findings from a nationally representative cohort

Nicotine and Tobacco Research

Volumn 22, Issue 9, 2020, Pages 1560-1568

  Watkins, Shannon Lea ^a   Thrul, Johannes ^b   Max, Wendy ^c   Ling, Pamela M ^d  

^a UNIVERSITY OF IOWA   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NICOTINE;

ADULT; AGE DISTRIBUTION; ARTICLE; BEHAVIOR THERAPY; CIGARETTE SMOKING; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NICOTINE REPLACEMENT THERAPY; POPULATION RESEARCH; PREDICTION; PRIORITY JOURNAL; SMOKING CESSATION; SMOKING CESSATION PROGRAM; SUBSTITUTION THERAPY; THERAPY EFFECT; TOBACCO DEPENDENCE; TOBACCO USE; ADOLESCENT; ELECTRONIC CIGARETTE; EPIDEMIOLOGY; HEALTH BEHAVIOR; MIDDLE AGED; PROCEDURES; PROGNOSIS; PSYCHOLOGY; SMOKING; THERAPY; UNITED STATES; YOUNG ADULT;

ADOLESCENT; ADULT; BEHAVIOR THERAPY; COHORT STUDIES; ELECTRONIC NICOTINE DELIVERY SYSTEMS; FEMALE; HEALTH BEHAVIOR; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; SMOKERS; SMOKING; SMOKING CESSATION; UNITED STATES; YOUNG ADULT;

EID: 85089801649     PISSN: 14622203     EISSN: 1469994X     Source Type: Journal    
DOI: 10.1093/ntr/ntz223     Document Type: Article

References (46)

1. Villanti AC, Niaura RS, Abrams DB, Mermelstein R. Preventing smoking progression in young adults: the concept of prevescalation. Prev Sci. 2019;20(3):377-384. doi:10.1007/s11121-018-0880-y
2. Doll R, Peto R, Boreham J, Sutherland I. Mortality in relation to smoking: 50 years' observations on male British doctors. BMJ. 2004;328(7455):1519. doi:10.1136/bmj.38142.554479.AE
3. Jha P, Ramasundarahettige C, Landsman V, et al. 21st-Century hazards of smoking and benefits of cessation in the United States. N Engl J Med. 2013;368(4):341-350.
4. Pirie K, Peto R, Reeves GK, Green J, Beral V; Million Women Study Collaborators. The 21st century hazards of smoking and benefits of stopping: a prospective study of one million women in the UK. Lancet. 2013;381(9861):133-141.
5. Diemert LM, Bondy SJ, Brown KS, Manske S. Young adult smoking cessation: predictors of quit attempts and abstinence. Am J Public Health. 2013;103(3):449-453.
6. McCarthy M, Siahpush M, Shaikh RA, Sikora Kessler A, Tibbits M. Social disparities in unaided quit attempts among daily current and former smokers: results from the 2010-2011 tobacco use supplement to the current population survey. Nicotine Tob Res. 2016;18(8):1705-1710.
7. Solberg LI, Asche SE, Boyle R, McCarty MC, Thoele MJ. Smoking and cessation behaviors among young adults of various educational backgrounds. Am J Public Health. 2007;97(8):1421-1426.
8. Curry SJ, Sporer AK, Pugach O, Campbell RT, Emery S. Use of tobacco cessation treatments among young adult smokers: 2005 National Health Interview Survey. Am J Public Health. 2007;97(8):1464-1469.
9. Hughes JR, Cohen B, Callas PW. Treatment seeking for smoking cessation among young adults. J Subst Abuse Treat. 2009;37(2):211-213.
10. Watkins SL, Thrul J, Max W, Ling P. Cold Turkey and Hot Vapes? A national study of young adult cigarette cessation strategies. Nicotine Tob Res. 2018;1-9. doi:10.1093/ntr/nty270
11. Suls JM, Luger TM, Curry SJ, Mermelstein RJ, Sporer AK, An LC. Efficacy of smoking-cessation interventions for young adults: a meta-analysis. Am J Prev Med. 2012;42(6):655-662.
12. The Clinical Practice Guideline Treating Tobacco Use and Dependence 2008 Update Panel Liaisons and Staff. A clinical practice guideline for treating tobacco use and dependence: 2008 update. A U.S. Public Health Service report. Am J Prev Med. 2008;35(2):158-176.
13. Cahill K, Stevens S, Perera R, Lancaster T. Pharmacological interventions for smoking cessation: an overview of reviews. 2013;(5):CD009329. doi:10.1002/14651858.CD009329.pub2
14. West R, Zhou X. Is nicotine replacement therapy for smoking cessation effective in the "real world"? Findings from a prospective multinational cohort study. Thorax. 2007;62(11):998-1002.
15. Kotz D, Brown J, West R. 'Real-world' effectiveness of smoking cessation treatments: a population study. Addiction. 2014;109(3):491-499.
16. Pierce JP, Gilpin EA. Impact of over-the-counter sales on effectiveness of pharmaceutical aids for smoking cessation. JAMA. 2002;288(10):1260-1264.
17. Heckman BW, Cummings KM, Kasza KA, et al. Effectiveness of switching smoking-cessation medications following relapse. Am J Prev Med. 2017;53(2):e63-e70.
18. Chaiton M, Diemert LM, Bondy SJ, et al. Real-world effectiveness of pharmaceutical smoking cessation aids: time-varying effects. Nicotine Tob Res. 2018;1-6. doi:10.1093/ntr/nty194
19. Hartmann-Boyce J, McRobbie H, Bullen C, Begh R, Stead LF, Hajek P. Electronic cigarettes for smoking cessation. Cochrane Database Syst Rev. 2016;(9):CD010216. doi:10.1002/14651858.CD010216.pub3
20. Kalkhoran S, Glantz SA. E-cigarettes and smoking cessation in real-world and clinical settings: a systematic review and meta-analysis. Lancet Respir Med. 2016;4(2):116-128.
21. Hajek P, Waller AP, Przulj D, et al. A randomized trial of E-cigarettes versus nicotine-replacement therapy. N Engl J Med. 2019;380(7):629-637. doi:10.1056/NEJMoa1808779
22. Committee on the Review of the Health Effects of Electronic Nicotine Delivery Systems. In: Stratton K, Kwan LY, Eaton DL, eds. Public Health Consequences of E-Cigarettes. Washington, DC: The National Academic Press; 2018. doi:10.17226/24952
23. Benmarhnia T, Pierce JP, Leas E, et al. Can E-cigarettes and pharmaceutical aids increase smoking cessation and reduce cigarette consumption? Findings from a nationally representative cohort of American smokers. Am J Epidemiol. 2018;187(11):2397-2404.
24. Berry KM, Reynolds LM, Collins JM, et al. E-cigarette initiation and associated changes in smoking cessation and reduction: the Population Assessment of Tobacco and Health Study, 2013-2015. Tob Control. 2018;28(1):42-49.
25. Vallone DM, Bennett M, Xiao H, Pitzer L, Hair EC. Prevalence and correlates of JUUL use among a national sample of youth and young adults. Tob Control. 2019;28(6):603-609.
26. United States Department of Health and Human Services, National Institutes of Health, National Institute on Drug Abuse, United States Department of Health and Human Services, Food and Drug Administration. Center for Tobacco Products. Population Assessment of Tobacco and Health (PATH) Study [United States] Public-Use Files. Ann Arbor, MI: Inter-university Consortium for Political and Social Research [distributor]. 28 September 2018. doi:10.3886/ICPSR36498.v8
27. Hyland A, Ambrose BK, Conway KP, et al. Design and methods of the Population Assessment of Tobacco and Health (PATH) Study. Tob Control. 2017;26(4):371-378.
28. Hymowitz N, Cummings KM, Hyland A, Lynn WR, Pechacek TF, Hartwell TD. Predictors of smoking cessation in a cohort of adult smokers followed for five years. Tob Control. 1997;6(suppl 2):S57-S62.
29. Hyland A, Li Q, Bauer JE, Giovino GA, Steger C, Cummings KM. Predictors of cessation in a cohort of current and former smokers followed over 13 years. Nicotine Tob Res. 2004;6(suppl 3):363-369.
30. Sung H, Wang Y, Yao T, Lightwood J, Max W. Polytobacco use and nicotine dependence symptoms among US adults, 2012-2014. Nicotine Tob Res. 2018;20(1):88-98.
31. Levy DE, Biener L, Rigotti NA. The natural history of light smokers: a population-based cohort study. Nicotine Tob Res. 2009;11(2):156-163.
32. Shiffman S, Kassel JD, Paty J, Gnys M, Zettler-Segal M. Smoking typology profiles of chippers and regular smokers. J Subst Abuse. 1994;6(1):21-35.
33. Brauer LH, Hatsukami D, Hanson K, Shiffman S. Smoking topography in tobacco chippers and dependent smokers. Addict Behav. 1996;21(2):233-238.
34. Trinidad DR, Perez-Stable EJ, Emery SL, White MM, Grana RA, Messer KS. Intermittent and light daily smoking across racial/ethnic groups in the United States. Nicotine Tob Res. 2009;11(2):203-210.
35. Jiang N, Gonzalez M, Ling PM, Glantz SA. Relationship of smokefree laws and alcohol use with light and intermittent smoking and quit attempts among US adults and alcohol users. PloS one 10(10):e0137023 2015;10(10):1-17. doi:10.1371/journal.pone.0137023
36. Zhou X, Nonnemaker J, Sherrill B, Gilsenan AW, Coste F, West R. Addictive behaviors attempts to quit smoking and relapse: factors associated with success or failure from the ATTEMPT cohort study. Addict Behav. 2009;34(4):365-373.
37. Chaiton M, Diemert L, Cohen JE, et al. Estimating the number of quit attempts it takes to quit smoking successfully in a longitudinal cohort of smokers. BMJ Open. 2016;6(6):e011045.
38. Schane RE, Prochaska JJ, Glantz SA. Counseling nondaily smokers about secondhand smoke as a cessation message: a pilot randomized trial. Nicotine Tob Res. 2013;15(2):334-342.
39. Jamal A, Phillips E, Gentzke AS, et al. Current cigarette smoking among adults-United States, 2016. Morb Mortal Wkly Rep. 2018;67(2):53.
40. Ussher M, Kakar G, Hajek P, West R. Dependence and motivation to stop smoking as predictors of success of a quit attempt among smokers seeking help to quit. Addict Behav. 2016;53:175-180.
41. Kulak JA, Cornelius ME, Fong GT, Giovino GA. Differences in quit attempts and cigarette smoking abstinence between whites and African Americans in the United States: literature review and results from the international tobacco control US survey. Nicotine Tob Res. 2016;18(suppl 1):S79-S87.
42. Zhang B, Cohen JE, Bondy SJ, Selby P. Duration of nicotine replacement therapy use and smoking cessation: a population-based longitudinal study. Am J Epidemiol. 2015;181(7):513-520.
43. Siahpush M, Shaikh RA, McCarthy M, Sikora Kessler A, Tibbits M, Singh GK. Association between duration of use of pharmacotherapy and smoking cessation: findings from a national survey. BMJ Open. 2015;5(1):e006229.
44. Whittaker R, McRobbie H, Bullen C, Rodgers A, Gu Y. Mobile phonebased interventions for smoking cessation. Cochrane Database Syst Rev. 2016;4(4):CD006611. doi:10.1002/14651858.CD006611.pub4
45. Vilardaga R, Casellas-Pujol E, McClernon JF, Garrison KA. Mobile applications for the treatment of tobacco use and dependence. Curr Addict Rep. 2019;6(2):86-97.
46. Kotz D, Brown J, West R. Prospective cohort study of the effectiveness of varenicline versus nicotine replacement therapy for smoking cessation in the "real world". BMC Public Health. 2014;14:1163. doi:10.1186/1471-2458-14-1163